False plasma data: US health official sorry

Washington, Aug. 25: Dr Stephen Hahn, the commissioner of the US Food and Drug Administration, apologised Monday after misrepresenting a key statistic on how effective blood plasma is for treating Covid-19 when announcing an emergency approval measure. The US on Sunday issued emergency approval for plasma taken from recovered Coronavirus patients, so that more people can get access to the experimental treatment.

But Hahn and other senior health officials came under fire from experts after repeating a claim made by President Donald Trump that blood plasma from recovered Covid-19 patients reduced mortality rates by 35 percent.

“What that means is — and if the data continue to pan out — 100 people who are sick with Covid-19, 35 would have been saved because of the administration of plasma,” Hahn said Sunday, after Trump had called it “a tremendous number”. Health secretary Alex Azar added: “I just want to emphasise this point, because I don’t want you to gloss over this number. We dream in drug development of something like a 35 percent mortality reduction. This is a major advance in the treatment of patients. This is a major advance.” Such a reduction would indeed be a game changer in the fight against the pandemic — but the statistic is false.

The officials said these results came from a study of 35,000 patients conducted by Mayo Clinic, but Dr Scott Wright, the study’s leader, told AFP it did not come from his institution’s research. He said he believed it might be an “integrated analysis” the FDA had arrived at by looking at both Mayo’s work and other studies.

FDA spokeswoman Emily Miller later tweeted that 35 percent referred to the relative difference in mortality risk between those patients in Mayo’s study who received a high level of antibodies against those who received a low level of antibodies.

“I have been criticized for remarks I made Sunday night about the benefits of convalescent plasma,” said Hahn in a tweet thread on Monday.